Cargando…
Comparative In vitro Metabolism of Enflicoxib in Dogs, Rats, and Humans: Main Metabolites and Proposed Metabolic Pathways
BACKGROUND: Enflicoxib is a non-steroidal anti-inflammatory drug of the coxib family characterized by a long-lasting pharmacological activity that has been attributed to its active metabolite E-6132. OBJECTIVES: The aim of this work was to explore enflicoxib biotransformation in vitro in humans, rat...
Autores principales: | Solà, Josep, Menargues, Àngel, Homedes, Josep, Salichs, Marta, Serafini, Maria Teresa, Encina, Gregorio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175088/ https://www.ncbi.nlm.nih.gov/pubmed/34886785 http://dx.doi.org/10.2174/1872312814666211209161933 |
Ejemplares similares
-
Pharmacokinetics of enflicoxib in dogs: Effects of prandial state and repeated administration
por: Homedes, Josep, et al.
Publicado: (2021) -
Selective inhibition of cyclooxygenase‐2 by enflicoxib, its enantiomers and its main metabolites in vitro in canine blood
por: Solà, Josep, et al.
Publicado: (2022) -
Pharmacology of enflicoxib, a new coxib drug: Efficacy and dose determination by clinical and pharmacokinetic‐guided approach for the treatment of osteoarthritis in dogs based on an acute arthritis induction model
por: Cendrós, Josep‐Maria, et al.
Publicado: (2021) -
Long-term safety evaluation of Daxocox(®) tablets (enflicoxib) in dogs after weekly oral administrations for seven months
por: Homedes, Josep, et al.
Publicado: (2021) -
Evaluation of the Genotoxic Potential of the Selective COX-2
Inhibitor Enflicoxib in a Battery of
in vitro
and
in vivo
Genotoxicity Assays
por: Guzmán, Antonio, et al.
Publicado: (2022)